Salute e Benessere

Radioligand Therapies Market to Show Immense Growth by 2034, Predicts…

Key Takeaways from the Radioligand Therapies Market Report Key Takeaways from the Radioligand Therapies Market Report Discover which therapies are expected to grab the radioligand therapies market share @ Radioligand Therapies Market Report Radioligand Therapies Market Dynamics The radioligand therapies market has witnessed significant dynamics driven by advancements in oncology and nuclear medicine. One of the key drivers of market growth is theincreasing incidence of cancer...

Voting Rights and Shares Capital of the Company

In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers)PARIS, July09, 2024(GLOBE NEWSWIRE) --Market: Euronext Paris / Nasdaq Euronext Compartment: BISIN code: FR0011341205 Nasdaq: NBTX Bloomberg: NANO:FP Reuters: NANO.PA Website:www.nanobiotix.comDateNumber of Shares Outstanding Total number of voting rightsTotal voting rights,...

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et…

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland) July 9, 2024– GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced the half-year report of the liquidity contract with Crédit Industriel et Commercial.Under the liquidity contract GENFIT has with Crédit Industriel et Commercial, the following resources appeared on the liquidity...

ONWARD® Medical Announces Publication Highlighting Evidence-based Programming…

Framework to determine stimulation parameters for ONWARD ARC-EX Therapy are published in the journal Neuromodulation: Technology at the Neural Interface Peer-reviewed publication is based on results from the Up-LIFT and LIFT Home studies EINDHOVEN, the Netherlands, July09, 2024(GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with...

Report on Carbios' liquidity contract with Natixis ODDO BHF

PRESS RELEASE REGULATED INFORMATION: ONGOINGReport on Carbios' liquidity contract with Natixis ODDO BHF Shares concerned: Carbios (ISIN code: FR0011648716)Market concerned: Euronext Growth Paris Clermont-Ferrand (France), 09 July 2024 (18:00 CEST).CARBIOS, (Euronext Growth Paris: ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, reports today about the liquidity contract...

IPSEN - Buy-back programme - Art 5 of MAR - Week 27 - 2024

Aggregated presentation by day and by market Purchases of own shares from July 1st to 5th 2024 Name of the IssuerIdentity code of the IssuerDay of the transactionIdentity code of the financial instrumentTotal daily volume (in number of shares)Daily weighted average purchase price of the sharesMarket (MIC Code) IPSEN549300M6SGDPB4Z94P1101/07/2024FR00102591504 400114,6643XPARIPSEN549300M6SGDPB4Z94P1101/07/2024...

Ipsen - June 2024 - Monthly information relative to the total number of voting…

Monthly information relative to the total number of voting rightsand shares composing the share capital(in accordance with Article L.233-8 II of the French Commercial Code andArticle 223-16 of the General Regulation of theAutorité des Marchés Financiers ) Market: Euronext ParisISIN Code: FR 0010259150 LEI: 549300M6SGDPB4Z94P11 DateTotal number of shares composing the share capitalTotal number of voting rights(1)30 June 202483,814,526Gross...

Global Udder Health Market worth $1.6 billion by 2029 driven by Automated…

Browse in-depth TOC on "Udder Health Market" Browse in-depth TOC on "Udder Health Market" 250 - Tables200 - Figures300 - Pages DeLaval ( Sweden ): Leader in Dairy Farming Solutions DeLaval, headquartered in Tumba,Sweden, specializes in dairy farming solutions globally. The company focuses on milking equipment, hygiene products, and farm supplies across over 100 markets, with notable operations in dairy-rich regions like theUSA,Canada, andChina. Acquiring...

Medical Biomimetic Market to hit USD 19.3 Billion by 2034 | Report by…

Owing to the growing number of chronic diseases across the world, the scope of the sector is expected to increase. Natural therapies for such chronic diseases are gaining traction in the contemporary world, which drives the demand for biomimetics. Owing to the growing number of chronic diseases across the world, the scope of the sector is expected to increase. Natural therapies for such chronic diseases are gaining traction in the contemporary world, which drives the demand for biomimetics...

Epigenetics Market to be Worth $6.33 Billion by 2031 - Exclusive Report by…

Epigenetics is a phenotypic alteration without permanent genotypic change using several methods, including DNA methylation, histone modification, RNA modification, etc. These modifications play a crucial role in diagnosing and prognosis diseases and disorders. Epigenetics finds its major application in oncology due to the global cancer burden and the growing adoption of precision cancer therapies. Epigenetics is a phenotypic alteration without permanent genotypic change using several methods,...

Clinion Applauded by Frost & Sullivan for Enabling Interoperability and…

Clinion's eClinical tools capture high-quality patient data, advancing trial operations and boosting the efficiency of clinical development programs. Its cloud-based EDC, RTSM, CTMS, and eCOA integrated platform offer biopharmaceutical sponsors a unified view of trial workflows, thus improving efficiency. The company's AI-enabled eClinical platform employs advanced automation technologies to speed up clinical study timelines and enhance visibility into all aspects of the process. The agile and…

Pascal Piedbois, MD, PhD joins One2Treat as Chief Medical Officer to advance…

One2Treat's innovative approach, driven by its Founder Marc Buyse, aims to reduce trial sample sizes and accelerate patient access to new treatments. One2Treat software helps incorporate multiple clinical outcomes that matter to the patient as early as the study design through robust statistical methodologies. Dr. Pascal Piedbois will be a key driver in this endeavor. One2Treat 's innovative approach, driven by its Founder Marc Buyse , aims to reduce trial sample sizes and accelerate...

Safe Life Completes Add-On Acquisition in the UK

The new addition in the UK with Defib Store broadens Safe Life's portfolio in the market and the combination of providing AED's and defibrillator cabinets will fortify Safe Life's position as the largest AED specialist provider in the UK. The new addition in the UK with Defib Store broadens Safe Life's portfolio in the market and the combination of providing AED's and defibrillator cabinets will fortify Safe Life's position as the largest AED specialist provider in the UK. "We are excited…

SkylineDx Announces All Patients Enrolled in Landmark Study MERLIN_001…

Independent prospective validation is crucial for GEP testing to show its clinical value and establish their cost-effectiveness [2]. Previous prospective data from the Netherlands affirmed the performance metrics published from multiple independent international retrospective cohorts. All of these publications conclude that the Merlin Assay can accurately identify patients at low risk for nodal metastasis. Independent prospective validation is crucial for GEP testing to show its clinical…

Pulnovo Medical Announces Joining PHA's (Pulmonary Hypertension Association)…

About PHA About PHA The PHA was founded in 1991 inFloridaand evolved into an international community of more than 16,000 people with PH, caregivers, family members and health care professionals. As one of the largest and oldest pulmonary hypertension association in the world, the PHA acts as a trusted liaison between the pulmonary hypertension community and industry and academic partners. About PADN Pulmonary Artery Denervation (PADN) is a percutaneous pulmonary artery...

Univar Solutions Appointed as Exclusive Distributor of VIZOR® Zinc Oxide Sun…

"We are thrilled that VIZOR selected Univar Solutions as its sole distribution partner for Super Zinc powders and dispersion products in Europe. This partnership not only significantly expands our range of sun care ingredients for beauty and personal care purposes, but also demonstrates our commitment to technical innovation ‒ supporting customers who are looking to formulate with top-quality, natural, and eco-friendly ingredients," shared James Peterson, Univar Solutions' global vice…

Jazz Pharmaceuticals Promotes Samantha Pearce to Chief Commercial Officer

Ms. Pearce joined Jazz as SVP, Europe and International, in 2020, and brings more than 30 years of commercial experience in the pharmaceutical industry. Since joining Jazz, she has instilled a commitment to a high-performance culture, growing Jazz's commercial brands and harnessing the potential of Jazz's European and International business to provide transformative medicines for patients in more than 50 countries. In her role as Chief Commercial Officer, she will be responsible for strategy and…

uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease…

~ Achieved statistically significant, dose-dependent, and durable evidence of potential therapeutic benefit; Patients receiving high-dose AMT-130 showed 80% slowing of disease progression in the composite Unified Huntington's Disease Rating Scale (cUHDRS) at 24 months compared to a propensity score-weighted external control ~ ~ Achieved statistically significant lowering of CSF neurofilament light protein (NfL) compared to baseline at 24 months in patients treated with AMT-130; Mean CSF...

Tilray Medical Announces Scientific Study on Medical Cannabis for Patients Over…

Older Patients Represent a Rapidly Growing Subset for Therapeutic Medical Cannabis Use for Pain, Sleep, Quality of Life and Co-Medication Medical Cannabis for Patients Over Age 50: A Multi-Site, Prospective Study of Patterns of Use and Health Outcomes.The Medical Cannabis in Older Patients Study(“MCOPS”) is a multi-site, prospective, observational study examining the real-world impact of medical use on patients over the age of 50 and under the guidance of a healthcare provider...

Gryphon Investors-Backed Vetnique Labs to Acquire U.K. Maker of YuMOVE

YuMOVE is the U.K.'s number one joint mobility supplement for dogs and cats and also offers supplements that support digestive health, anxiety, dermatological and dental needs. Based in Hertfordshire, U.K., and founded two decades ago by Dr. John Howie DL and John Davies, YuMOVE aims to provide pets and their owners with scientifically supported supplements to manage chronic health conditions. It is also a certified B Corporation, a distinction achieved based on its high standards in ESG…

STALICLA appoints Dr. Purnanand Sarma, PhD, as Chair of the Board of Directors

Press ReleaseDr. Sarma brings exceptional expertise in all facets of the pharmaceutical and biotechnology business, from scaling platforms to developing therapeuticsGeneva, Switzerland – July 9, 2024– STALICLA SA, a Swiss neuro precision biotech company dedicated to developing precision medicine-based treatments for neurodevelopmental and neuropsychiatric disorders, such as autism spectrum disorder, announced today the appointment of Dr. Purnanand Sarma, PhD, as Chair of its Board...

Global Sacral Nerve Stimulation Market Size to worth $634.1 million by 2030…

Market Dynamics: Market Dynamics : The global sacral nerve stimulation market is witnessing significant growth due to increasing prevalence of overactive bladder and urge incontinence globally. According to the National Association for Continence, over 25 million Americans experience overactive bladder which is a progressive disease and more than 50% of the Americans between ages of 40 to 60 years are affected by overactive bladder. Further, rise in geriatric population and surge in obesity...

Global Workout Supplements Market Size to worth $36.38 billion by 2030, growing…

Market Dynamics: Market Dynamics : The global workout supplements market is witnessing significant growth owing to rising awareness about health and fitness among consumers. Growing consumption of protein supplements to build muscles and pre-workout supplements to boost energy levels is driving the market growth. Additionally, easy availability of supplements through online distribution channels and celebrity endorsements promoting the usage of supplements is further augmenting the market...

iOnctura announces expansion of roginolisib clinical trial program to NSCLC

Emerging clinical and translational biomarker data supports the hypothesis that combining roginolisib with a programmed death receptor-1 (PD-1) targeting agent, with or without docetaxel, may prevent or reverse drug resistance in NSCLC and may show synergistic anti-tumor immune activity without significant addition of toxicity3. Emerging clinical and translational biomarker data supports the hypothesis that combining roginolisib with a programmed death receptor-1 (PD-1) targeting agent, with…

Altri Comunicati